Factors associated with bisphosphonate treatment failure in postmenopausal women with primary osteoporosis. [electronic resource]
- Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA Apr 2014
- 1401-10 p. digital
Publication Type: Journal Article; Observational Study
1433-2965
10.1007/s00198-014-2619-3 doi
Absorptiometry, Photon--methods Aged Aged, 80 and over Alendronate--therapeutic use Alkaline Phosphatase--blood Biomarkers--blood Bone Density--drug effects Bone Density Conservation Agents--therapeutic use Bone Remodeling--drug effects Diphosphonates--therapeutic use Etidronic Acid--analogs & derivatives Female Femur Neck--physiopathology Follow-Up Studies Hip Joint--physiopathology Humans Lumbar Vertebrae--physiopathology Medication Adherence Middle Aged Osteoporosis, Postmenopausal--drug therapy Osteoporotic Fractures--physiopathology Risedronic Acid Risk Factors Smoking--adverse effects Treatment Failure